LOOMIS SAYLES & CO L P - DICERNA PHARMACEUTICALS INC ownership

DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 189 filers reported holding DICERNA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 1.57 and the average weighting 0.2%.

Quarter-by-quarter ownership
LOOMIS SAYLES & CO L P ownership history of DICERNA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2021$58,221,000
+43.1%
1,560,057
-2.0%
0.07%
+34.0%
Q1 2021$40,696,000
+34.7%
1,591,568
+16.1%
0.05%
+32.5%
Q4 2020$30,209,000
+58.6%
1,371,272
+29.6%
0.04%
+42.9%
Q3 2020$19,042,000
+3.4%
1,058,455
+46.0%
0.03%
-6.7%
Q2 2020$18,415,000725,0030.03%
Other shareholders
DICERNA PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 1,355,392$29,859,0006.21%
Bain Capital Life Sciences Investors, LLC 3,080,237$67,858,0004.26%
DAFNA Capital Management LLC 587,756$12,948,0003.85%
SILVERARC CAPITAL MANAGEMENT, LLC 227,388$5,009,0002.91%
RTW INVESTMENTS, LP 7,253,857$159,802,0002.68%
Parkman Healthcare Partners LLC 331,513$7,303,0001.87%
Evolutionary Tree Capital Management, LLC 60,864$1,341,0001.02%
Eagle Health Investments LP 69,000$1,520,0000.97%
Woodline Partners LP 1,358,796$29,934,0000.79%
Affinity Asset Advisors, LLC 40,000$881,0000.47%
View complete list of DICERNA PHARMACEUTICALS INC shareholders